In the early stage of platinum chemotherapy in ovarian cancer, cellular DNA damage increases HDAC2 expression, which induces chromatin remodeling and reduces the inhibitory effect of platinum on tumor cells (13). The gene discussed is HDAC2; the disease is ovarian carcinoma.